Diabetes drugs test a new side effect: slowing down symptoms of Parkinson's
Briefly

from english.elpais.com9 months ago
GLP-1 receptor agonists show potential in impacting diseases like Alzheimer's and Parkinson's positively, beyond just treating diabetes and obesity.
english.elpais.comhttps://english.elpais.com/science-tech/2024-05-01/diabetes-drugs-test-a-new-side-effect-slowing-down-symptoms-of-parkinsons.html
Recent research suggests that Parkinson's patients treated with lixisenatide, a diabetes drug, maintained their motor abilities without major changes for a year, indicating promising outcomes.
english.elpais.comhttps://english.elpais.com/science-tech/2024-05-01/diabetes-drugs-test-a-new-side-effect-slowing-down-symptoms-of-parkinsons.html
Read at english.elpais.com
#glp-1-receptor-agonists #diabetes-treatment #obesity-treatment #alzheimers-disease #parkinsons-disease
[
|
]